Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jul 15, 2026
Stephen Brozak's Stock Ratings
WBB Securities Analyst
Stephen Brozak is an analyst at WBB Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
25.2%
Smart Score
Overall Average Return Percentile
81st
Number of Ratings
4
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/05/2024 | CDTX | Buy Now | Cidara Therapeutics | — | — | $40 → $45 | Maintains | Strong Buy | Get Alert | |
| 04/25/2024 | CDTX | Buy Now | Cidara Therapeutics | — | — | → $40 | Maintains | Strong Buy | Get Alert | |
| 06/09/2020 | ARCT | Buy Now | Arcturus Therapeutics | $6.39 | 385.13% | → $31 | Downgrade | Strong Buy → Hold | Get Alert | |
| 01/08/2020 | PRTK | Buy Now | Paratek Pharmaceuticals | — | — | → $6 | Initiates | → Speculative Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved